[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]
- PMID: 20037266
- DOI: 10.3350/kjhep.2009.15.4.474
[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]
Abstract
Background/aims: Radiofrequency ablation (RFA) is an established curative therapeutic modality for unresectable hepatocellular carcinoma (HCC), and transarterial chemoembolization (TACE) has been used as a palliative treatment for inoperable HCC. It is still unknown whether RFA and TACE are equally effective for improving the survival of patients with unresectable HCC that is amenable to either treatment. The aim of this retrospective study was to compare the clinical impacts of two treatments, and analyze the prognostic factors for recurrence and survival.
Methods: Ninety-three patients with a single HCC smaller than 4 cm who showed complete responses (complete ablation or complete lipiodol tagging) after treatment with RFA (n=43) or TACE (n=50) between January 2002 and February 2009 were investigated. Univariate and multivariate analyses were performed for 13 potential prognostic factors using the Cox proportional-hazards model.
Results: The time-to-recurrence rates at 1, 2, and 3 years after treatment were 32.9%, 44.3%, and 55.4%, respectively, for the RFA group, and 42%, 68.3%, 71.7% for the TACE group. The probability of survival at 1, 2, and 3 years was 97.7%, 77.4%, and 63.1%, respectively, for the RFA group, and 95.9%, 76.1%, and 60.2% for the TACE group. The time-to-recurrence and overall survival rates did not differ significantly between the two treatment groups. A multivariate Cox proportional-hazards model revealed that a tumor size larger than 3 cm and lower serum albumin levels were independent risk factors for recurrence, and that being male, being seropositive for hepatitis B surface antigen, and having a higher serum albumin level were independent favorable prognostic factors for survival.
Conclusions: TACE and RFA exhibited similar therapeutic effects in terms of recurrence and survival for patients with a single HCC smaller than 4 cm, if they could exhibited complete responses.
Similar articles
-
Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.Arch Surg. 2006 Dec;141(12):1231-6. doi: 10.1001/archsurg.141.12.1231. Arch Surg. 2006. PMID: 17178966
-
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.Liver Transpl. 2011 May;17(5):556-66. doi: 10.1002/lt.22273. Liver Transpl. 2011. PMID: 21506244
-
Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.J Gastroenterol Hepatol. 2008 Mar;23(3):482-90. doi: 10.1111/j.1440-1746.2007.05262.x. Epub 2007 Dec 13. J Gastroenterol Hepatol. 2008. PMID: 18086115
-
Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma.Surg Laparosc Endosc Percutan Tech. 2010 Jun;20(3):130-40. doi: 10.1097/SLE.0b013e3181d823df. Surg Laparosc Endosc Percutan Tech. 2010. PMID: 20551807 Review.
-
Recent advances of radiofrequency ablation for early hepatocellular carcinoma.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:115-22. doi: 10.1111/j.1440-1746.2010.06543.x. J Gastroenterol Hepatol. 2011. PMID: 21199522 Review.
Cited by
-
Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy.BJS Open. 2024 Jan 3;8(1):zrad155. doi: 10.1093/bjsopen/zrad155. BJS Open. 2024. PMID: 38242573 Free PMC article.
-
Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization.World J Gastroenterol. 2014 Jun 14;20(22):6995-7004. doi: 10.3748/wjg.v20.i22.6995. World J Gastroenterol. 2014. PMID: 24944494 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous